Tag Archives: IP

WTO deal not enough for med access: Experts – Times of India

MUMBAI: The WTO deal on the proposed patent waiver for all Covid medical tools appears substantially “watered down” as it fails to address monopolies and access barriers in key therapeutics and diagnostics. After nearly two years of negotiations, the TRIPS (Trade-Related Aspects of Intellectual Property Rights) agreement decision announced in …

Read More »